DARIOHEALTH CORP.

Profile

Company Names

DARIOHEALTH CORP.
LABSTYLE INNOVATIONS CORP.

Addresses

322 W 57TH ST. #33B, NEW YORK, NY 10019

18 W 18TH ST., 5TH FLOOR, NEW YORK, NY 10011

142 W. 57TH ST., 8TH FLOOR, NEW YORK, NY 10019

8 HATOKHEN ST., CAESAREA INDUSTRIAL PARK, L3 3088900

8 HATOKHEN STREET, CAESAREA INDUSTRIAL PARK, L3 3890000

HALAMISH 9, CAESAREA, L3 38900

9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, L3 38900

HALAMISH 9, CAESAREA INDUSTRIAL PARK, L3 38900

40 EAST MAIN STREET, NEWARK, DE 19711

350 FIFTH AVENUE, 59TH FLOOR, NEW YORK, NY 10018

Phone Numbers

972-4-770-6377
646.665.4667
(646) 665-4667
972-4-770-4055
(972)-(3)-6222929
+972-4-7706377
646-259-3321
646-652-6531

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$286,502,429.00

Number of Funding Rounds:

23
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
23
2025-09-22 
$17,500,000.00 
$17,500,000.00 
$0.00 
Equity 
22
2025-01-07 
$6,800,000.00 
$6,800,000.00 
$0.00 
Equity 
21
2024-12-16 
$18,805,000.00 
$18,805,000.00 
$0.00 
Equity 
20
2024-02-15 
$22,422,000.00 
$22,422,000.00 
$0.00 
Equity 
19
2023-05-01 
$15,400,000.00 
$15,400,000.00 
$0.00 
Equity 
18
2021-06-07 
$24,000,000.00 
$24,000,000.00 
$0.00 
Equity 
17
2021-02-04 
$31,000,000.00 
$31,000,000.00 
$0.00 
Equity 
16
2020-07-31 
$28,590,801.00 
$30,000,000.00 
$1,409,199.00 
Equity 
15
2020-02-01 
$70,000,000.00 
$70,000,000.00 
$0.00 
Equity 
14
2019-11-27 
$21,375,000.00 
$25,000,000.00 
$3,625,000.00 
Equity 
13
2018-12-14 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
12
2018-02-28 
$6,622,565.00 
$6,622,565.00 
$0.00 
Equity 
11
2017-01-09 
$5,100,000.00 
$5,100,000.00 
$0.00 
Equity 
10
2015-11-19 
$399,999.00 
$399,999.00 
$0.00 
Equity 
9
2015-07-23 
$789,550.00 
$2,255,391.00 
$1,465,841.00 
Equity 
8
2015-05-15 
$461,673.00 
$461,673.00 
$0.00 
Equity 
7
2015-02-25 
$1,631,560.00 
$3,846,000.00 
$2,214,440.00 
Equity 
6
2014-09-23 
$4,235,000.00 
$4,235,000.00 
$0.00 
Equity 
5
2014-02-18 
$4,186,681.00 
$4,186,681.00 
$0.00 
Equity 
4
2013-04-05 
$1,675,000.00 
$10,000,000.00 
$8,325,000.00 
Equity 
3
2012-09-28 
$1,202,600.00 
$2,750,000.00 
$1,547,400.00 
Equity 
2
2012-08-31 
$500,000.00 
$1,500,000.00 
$1,000,000.00 
Equity 
1
2011-10-27 
$805,000.00 
$3,000,000.00 
$2,195,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DROR 
 
BACHER 
EXECUTIVE OFFICER
YOSSI 
 
BAHAGON 
DIRECTOR
OFER 
 
BARNEA, PH.D. 
EXECUTIVE OFFICER
ZVI 
 
BEN DAVID 
EXECUTIVE OFFICER, DIRECTOR
SHILO 
 
BEN ZEEV 
EXECUTIVE OFFICER, DIRECTOR
ZVI 
 
BEN-DAVID 
EXECUTIVE OFFICER
ODED 
 
COHEN 
EXECUTIVE OFFICER
RAPHAEL 
 
EREZ 
EXECUTIVE OFFICER, DIRECTOR
YALON 
 
FARHI 
DIRECTOR
CHEN 
 
FRANCO-YEHUDA 
EXECUTIVE OFFICER, DIRECTOR
SHOSHANA 
 
FRIEDMAN 
EXECUTIVE OFFICER
OREN 
 
FUERST, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
OREN 
 
FUERST, PHD 
DIRECTOR
MORDECHI 
 
HERSHKOWITZ 
EXECUTIVE OFFICER
MALCOLM 
 
HOELEIN 
DIRECTOR
ALLEN 
 
KAMER 
DIRECTOR
JON 
 
KAPLAN 
DIRECTOR
STEVEN 
 
KAPLAN 
DIRECTOR
HILA 
 
KARAH 
DIRECTOR
DENNIS 
 
MATHEIS 
DIRECTOR
DENNIS 
 
MATTHESIS 
DIRECTOR
DENNIS 
M. 
MCGRATH 
DIRECTOR
DENNIS M. 
 
MCGRATH 
DIRECTOR
NAHUM 
 
MELUMAD 
DIRECTOR
NAHUM 
D. 
MELUMAD 
DIRECTOR
GLEN 
 
MOLLER 
DIRECTOR
GLEN 
D. 
MOLLER 
DIRECTOR
JARRY 
 
OLIVIER 
EXECUTIVE OFFICER
EREZ 
 
RAPHAEL 
EXECUTIVE OFFICER, DIRECTOR
YOAV 
 
SHAKED 
DIRECTOR, EXECUTIVE OFFICER
YADIN 
D. 
SHEMMER 
DIRECTOR
ADAM 
 
STERN 
DIRECTOR
PROLOR BIOTECH, INC.   |  LABSTYLE INNOVATIONS CORP.   |  MATINAS BIOPHARMA HOLDINGS, INC.   |  TCG PRIVATE SELECT PARTNERS, L.P.   |  DANCE BIOPHARM INC.   |  360 ENERGY OPPORTUNITY FUND, LP   |  ELEVEN JAMES, INC.   |  DANCE BIOPHARM HOLDINGS, INC.   |  ATLAS ENHANCED ACCESS FUND LP   |  GC OPPORTUNITIES I PRIVATE FUND, LP   |  FUNDAMENTAL PARTNERS III ACCESS FUND LP   |  TCG PRIVATE SELECT PARTNERS II, L.P.   |  CCA PINECREST INVESTORS, LP   |  COBBLESTONE PRIVATE REAL ESTATE FUND, LP   |  REAL ESTATE SENIOR LOAN ACCESS FUND, LP   |  PEAK MULTIFAMILY I ACCESS FUND, LP   |  LGA INCOME PLUS FUND, LP   |  GC OPPORTUNITIES 2 PRIVATE FUND LP   |  HCA SPECIAL OPPORTUNITIES FUND, LP   |  HCA GLOBAL ALPHA FUND LP   |  HCA GLOBAL ALPHA FUND OFFSHORE LTD   |  COBBLESTONE PRIVATE CREDIT FUND, LP   |  EMPIRICAL ALTERNATIVE INCOME FUND, LP   |  ALIGN IMPACT FUND II, LP   |  HCA WINDACRE ACCESS FUND, LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA I   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES PLANT PROTEIN I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES PLANT PROTEIN I   |  HYDROFARM HOLDINGS GROUP, INC.   |  SHOREPOINT INCOME FUND I LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES HOSPITALITY I   |  TCG PRIVATE SELECT PARTNERS III LP   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FANTASY SPORTS I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH I   |  AERAMI THERAPEUTICS HOLDINGS, INC.   |  DARIOHEALTH CORP.   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES DIGITAL FREIGHT NETWORK I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AGRITECH II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FINTECH I   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES AGRITECH II   |  SPRING TARGETED OPPORTUNITY III LLC   |  AGRITECH QP PARTNERS LLC - SERIES HB-1   |  AGRITECH PARTNERS LLC - SERIES HB-1   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE II   |  SPRING TARGETED OPPORTUNITY IV LLC   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH V   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES HEALTHTECH I   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VI   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VI   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES FINTECH III   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VIII   |  AEGIS SPECIAL SITUATIONS QP FUND LLC - SERIES MEDTECH VIII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH VII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH IX   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH X   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH II   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XII   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES MEDTECH XI   |  PURSUIT FUND ADVISERS LLC   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES AEROSPACE IV   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES BIG DATA III   |  AEGIS SPECIAL SITUATIONS FUND LLC - SERIES DAS I
RICHARD 
STONE 
DIRECTOR
RICHARD 
B. 
STONE 
DIRECTOR
RICHARD B. 
 
STONE 
DIRECTOR
DAVID 
 
WEINTRAUB 
DIRECTOR
DAVID 
 
WEINTRAUB, MD 
DIRECTOR, EXECUTIVE OFFICER
RAMI 
 
YEHUDIHA 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER TECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2025-09-22 
D
OTHER TECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2024-12-16 
D
OTHER TECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2025-01-07 
D
OTHER TECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2024-02-15 
D
OTHER TECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2023-05-01 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2021-06-07 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2021-02-04 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2020-02-01 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2020-07-31 
D/A
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2019-11-27 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2019-11-27 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2018-12-14 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2018-02-28 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
Equity 
2017-01-09 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
$1 - $1,000,000 
Equity 
2015-11-19 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
$1 - $1,000,000 
Equity 
2015-07-23 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
$1 - $1,000,000 
Equity 
2015-05-15 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
NO REVENUES 
Equity 
2015-02-25 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
NO REVENUES 
Equity 
2014-09-23 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
NO REVENUES 
Equity 
2014-02-18 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
NO REVENUES 
Equity 
2013-04-05 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
NO REVENUES 
Equity 
2012-09-28 
D
BIOTECHNOLOGY 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
NO REVENUES 
Equity 
2012-08-31 
D
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2011-10-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
AEGIS CAPITAL CORP.
NONE
NONE
COWEN AND COMPANY, LLC
NONE
NONE
STIFEL, NICOLAUS + COMPANY, INCORPORATED
793
NONE
NONE
STERNAEGIS VENTURES
NONE
NONE
AEGIS CAPITAL CORP.
NEWPORT COAST SECURITIES, INC.
MAXIM GROUP LLC
NONE
NONE
NEWPORT COAST SECURITIES, INC.
NONE
NONE
NEWPORT COAST SECURITIES, INC.
NONE
NONE
ROTH CAPITAL PARTNERS LLC
NONE
NONE
AEGIS CAPITAL CORP.
NONE
NONE
SPENCER TRASK VENTURES, INC.
NONE
NONE
CHARLES VISTA LLC
NONE
NONE
MEDITERRANEAN SECURITIES GROUP, LLC